VOX Voxel S.A.

37.94USD152.60 PLN · GPW+1.46%Mkt Cap: 398.44M USDP/E: 13.85

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical tri…

Key Statistics

Company
Market Cap398.44M USD
Enterprise Value431.02M USD
Revenue (TTM)159.26M USD
Gross Profit41.75M USD
Net Income (TTM)24.50M USD
Revenue/Share15.16 USD
Last Price37.94 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees356
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLVOXEL00014
Valuation
P/E (Trailing)13.85
P/E (Forward)15.60
PEG—
EV/EBITDA8.94
EV/Revenue2.71
P/S2.50
P/B3.64
EPS (TTM)2.74 USD
EPS (Forward)—
52W Range
23.3280% of range41.52
52W High41.52 USD
52W Low23.32 USD
Profitability
Gross Margin28.77%
Oper. Margin24.59%
EBITDA Margin30.26%
Profit Margin16.88%
ROE24.10%
ROA13.94%
ROIC18.45%
ROCE23.93%
Growth
Revenue Growth45.10%
Earnings Growth49.00%
Cash Flow & Leverage
Operating CF29.01M USD
CapEx (TTM)18.85M USD
FCF Margin7.75%
FCF Yield3.10%
Net Debt30.77M USD
Net Debt/EBITDA0.64
Net Debt/FCF2.49
Balance Sheet
Debt/Equity0.45
Current Ratio1.52
Quick Ratio1.22
Book Value/Sh10.42 USD
Cash/Share0.83 USD
Dividends
Fwd Div Rate0.62 USD
Trail. Div Rate0.62 USD
Div. Yield1.66%
5Y Avg Yield3.15%
Payout Ratio42.99%
Ex-Div DateSep 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)38.05 USD
Upside (mean)+0.3%
Target Range35.65 USD – 40.15 USD
35.65+0.3% to mean40.15
# Analysts3
Ownership
Shares Out.10.50M
Float5.04M
Insiders37.43%
Institutions31.89%
Technical
SMA 5037.05 (+2.4%)
SMA 20031.19 (+21.6%)
Beta0.50
S&P 52W Chg12.00%
Avg Vol (30d)8.76K
Avg Vol (10d)11.01K
Technical Indicators
RSI (14)51.7
MACD0.5248
MACD Signal1.2553
MACD Hist.-0.7305
BB Upper40.06 USD
BB Middle38.28 USD
BB Lower36.49 USD
BB Width9.33%
ATR (14)1.304 USD
Vol Ratio (20d)1.00x

About Voxel (WSE: VOX)

›

Voxel (WSE: VOX) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 356 employees.

The shares were at 152.60 PLN on 19 November 2026, down 3.4% over 52 weeks. Its 52-week range is 93.80 PLN to 167.00 PLN: the price is 8.6% below the high and 62.7% above the low.

At a market capitalisation of 1.60B PLN, it trades at 13.8 times trailing earnings and 15.6 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 61% for VOX. It pays a dividend yielding 1.66% (it pays out 43% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Voxel reports return on equity of 24.1%, an operating margin of 24.6% and revenue up 45.1% year over year.

Its debt exceeds its cash by 123.77M PLN, a debt-to-equity ratio of 0.45. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 153.07 PLN is 0.3% above the current price.